Regulations.gov document
Draft Guidance for Industry on Chronic Hepatitis C Virus Infection: Developing…
Notice · FDA-2013-D-1170 · posted Oct 23, 2013
Key facts
| Document ID | FDA-2013-D-1170-0001 |
|---|---|
| Title | Draft Guidance for Industry on Chronic Hepatitis C Virus Infection: Developing Direct-Acting Antiviral Drugs for Treatment; Availability |
| Document type | Notice |
| Subtype | Notice of Availability |
| Agency | FDA |
| Docket | FDA-2013-D-1170 |
| Posted | Oct 23, 2013 |
| Federal Register citation | 78 FR 63218 |
| FR document number | 2013-24785 |
| Comment period opens | Oct 23, 2013 |
| Comments due | Dec 24, 2013 |
| Effective date | Oct 23, 2013 |
At a glance
- 1–9 Pages
- No Open for comment
- 10–99 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: